| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 73.37B | 69.56B | 67.95B | 70.47B | 66.78B | 72.31B |
| Gross Profit | 13.63B | 12.01B | 10.81B | 11.62B | 10.96B | 12.51B |
| EBITDA | 7.55B | 5.46B | 4.43B | 5.29B | 5.03B | 5.91B |
| Net Income | 3.18B | 2.20B | 2.01B | 2.17B | 2.06B | 2.99B |
Balance Sheet | ||||||
| Total Assets | 55.99B | 64.15B | 55.25B | 56.13B | 51.90B | 54.08B |
| Cash, Cash Equivalents and Short-Term Investments | 7.84B | 10.39B | 10.99B | 9.80B | 9.29B | 12.41B |
| Total Debt | 4.14B | 11.98B | 5.39B | 6.38B | 3.95B | 1.58B |
| Total Liabilities | 21.49B | 29.47B | 21.98B | 24.28B | 21.55B | 24.40B |
| Stockholders Equity | 34.05B | 34.22B | 32.82B | 31.42B | 29.96B | 29.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.44B | 3.72B | -1.02B | -2.85B | 7.99B |
| Operating Cash Flow | 0.00 | 621.00M | 7.07B | 560.00M | -1.03B | 10.45B |
| Investing Cash Flow | 0.00 | -6.50B | -3.63B | -1.29B | -2.09B | -2.66B |
| Financing Cash Flow | 0.00 | 5.33B | -2.26B | 1.20B | 502.00M | -4.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥53.30B | 7.30 | ― | 3.78% | 11.81% | 52.35% | |
68 Neutral | ¥47.17B | 4.67 | ― | 2.26% | 12.93% | 98.16% | |
65 Neutral | ¥52.16B | 9.11 | ― | 2.84% | 15.45% | 43.95% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥74.08B | 26.09 | ― | 0.79% | -8.53% | -83.61% | |
60 Neutral | ¥60.74B | 19.35 | ― | 1.57% | 11.01% | 231.83% | |
48 Neutral | ¥73.35B | -149.33 | ― | 2.73% | -3.59% | 49.34% |